Merck & Co. didn’t do any significant studies on whether Vioxx could cause heart attacks or other serious cardiovascular problems before the popular painkiller went on the market in 1999, the ...

An experimental Merck & Co drug succeeded in preventing clinically serious cytomegalovirus (CMV) following bone marrow transplant and was associated with a lower death rate compared with placebo in a ...

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- Merck today announced a non-exclusive license agreement with Laboratory Corporation of America ® Holdings (LabCorp ®) for the commercialization of a genetic ...

Signage is seen at the Merck & Co. headquarters in Kenilworth, New Jersey (Reuters) - Merck & Co said on Wednesday it plans to conduct clinical trials testing its human papillomavirus (HPV) vaccine ...

Merck (NYSE:MRK) has initiated a late-stage trial to test its experimental drug, MK-1084, in combination with its anti-PD1 immunotherapy KEYTRUDA (pembrolizumab) for the first-line treatment of ...

One of the largest pharmaceutical companies in the world is testing the delivery of vaccines via drone to get them to patients faster. Merck is working with Volansi, a commercial drone delivery ...

Merck has tightened its ties to Starpharma as it continues to build out its antibody-drug conjugate (ADC) capabilities, signing a second agreement that will enable it to evaluate candidates based on a ...

(Reuters) - Pivotal trial results for Merck & Co Inc's immunotherapy drug Keytruda show that it lengthened survival by three months, or nearly 40 percent, for patients with advanced bladder cancer who ...

Drugmakers have speculated about delivering temperature-sensitive vaccines and drugs to remote locations using drones. Now, Merck & Co. is testing the method. Merck initiated the idea, and a ...

Merck is partnering with a digital health startup to see if smartphone data can be used to identify digital endpoints for Alzheimer’s drug development. The study will use a research platform developed ...